Blue Cross Transport Pty Limited is a limited by shares, Australian proprietary company. This corporation was registered on 2008-05-29 and was issued with the 131351561 ACN. Its Australian Business Number is 50131351561. Since 2014-09-23, the company is headquartered in NSW, post code 2282. The previous headquarters were located in NSW 2282 (from 2014-01-20 to 2014-09-23), NSW 2282 (from 2008-05-29 to 2014-01-20). Blue Cross Transport Pty Limited was registered for the GST on 2008-05-29. The company has also used 2 business names, namely Blue Cross Transport from 2023-05-01 to 2023-06-12, G & J Deliveries from 2017-10-09. The above data comes from the ABN database which was updated on 2023-06-12.
Status | From | To |
---|---|---|
Active | Thursday 29th May 2008 | current |
Name | From | To |
---|---|---|
G & J Deliveries Pty Limited | Saturday 13th May 2023 | current |
Blue Cross Transport Pty Limited | Thursday 29th May 2008 | Saturday 13th May 2023 |
Name | From | To |
---|---|---|
Blue Cross Transport | Monday 1st May 2023 | Monday 12th June 2023 |
G & J Deliveries | Monday 9th October 2017 | Friday 7th May 2021 |
Location | From | To |
---|---|---|
NSW 2282 | Tuesday 23rd September 2014 | current |
NSW 2282 | Monday 20th January 2014 | Tuesday 23rd September 2014 |
NSW 2282 | Thursday 29th May 2008 | Monday 20th January 2014 |
Status | From | To |
---|---|---|
Registered | Thursday 29th May 2008 | current |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.